Genedata Biologics
Streamlining biotherapeutic discovery, this industry-leading software supports the development of bispecifics, ADCs, TCRs, CAR-Ts, and AAVs. By integrating all R&D workfl... Streamlining biotherapeutic discovery, this industry-leading software supports the development of bispecifics, ADCs, TCRs, CAR-Ts, and AAVs. By integrating all R&D workflows and automating various tasks, it enhances research efficiency, enabling scientists to focus on innovation. Its centralized data management facilitates real-time access and collaboration across teams.
Top Genedata Biologics Alternatives
Genedata Imagence
Genedata Imagence revolutionizes high-content screening analysis by enabling biologists to harness deep learning for cellular phenotype classification in imaging data....
Healnet
Healnet revolutionizes drug discovery by leveraging AI to analyze extensive drug and disease data, uncovering novel treatment connections for rare...
Chemical Computing Group
Offering advanced tools for 3D molecular visualization, Chemical Computing Group empowers researchers in structure-based and ligand-based design, antibody development, and...
FCS Express
FCS Express™ seamlessly transforms raw flow cytometry data into clear, presentation-ready results with remarkable efficiency. Designed for researchers familiar with...
DNAnexus Apollo
DNAnexus Apollo™ revolutionizes precision drug discovery by integrating multimodal data, analytics, and collaboration tools in a secure cloud platform. It...
Iktos
Makya revolutionizes de novo drug design with its user-friendly AI-driven SaaS platform, emphasizing Multi-Parametric Optimization (MPO). It accelerates compound development...
Recursion
Leveraging proprietary biological, chemical, and real-world patient data, this advanced biotechnology company utilizes a supercomputer, BioHive-2, to scale up drug...
3decision
3decision® serves as a centralized cloud-based repository for 3D protein structures, integrating data from public and proprietary sources. It streamlines...
Atomwise
Harnessing the power of AI, this platform revolutionizes drug discovery by integrating machine learning with vast chemical libraries. Its innovative...
BIOiSIM
A pioneering virtual drug development engine, BIOiSIM® streamlines drug discovery by identifying compounds likely to succeed in treating specific diseases....
SCIEX
This drug discovery software seamlessly integrates with high-performance LC-MS/MS systems, enhancing data acquisition and analysis for precise molecular detection. With...
Genomenon
Accelerating NGS variant interpretation, this drug discovery software enables rapid exploration of genomic literature, offering insights into over 26 million...
Phoenix PK/PD Platform
The Phoenix™ PK/PD Platform equips scientists with advanced tools for pharmacokinetic and pharmacodynamic modeling, facilitating robust analysis from preclinical to...
ArgusLab
ArgusLab is a molecular modeling and drug design software designed for Windows, gaining popularity despite its age, with over 20,000...
Schrödinger
Transforming drug discovery and materials research, Schrödinger's advanced molecular modeling platform leverages physics-driven computational solutions for predictive modeling and data...
Company Information
- Company: Genedata
- Country: Switzerland
Top Genedata Biologics Features
- Centralized data management system
- Comprehensive discovery workflow integration
- Real-time data accessibility
- High-throughput automation capabilities
- Flexible business model options
- Advanced biotherapeutics design tools
- Seamless laboratory equipment integration
- Supports multi-specific antibody formats
- End-to-end gene therapy coverage
- Streamlined ADC candidate management
- Robust candidate developability assessment
- Integrated sample tracking functionalities
- Enhanced collaboration across teams
- Systematic screening data processing
- Efficient B cell-derived antibody R&D
- Automated task scheduling management
- Comprehensive protein analytics integration
- Customizable user interfaces
- Rapid deployment capabilities
- Continuous improvement of candidate properties
